BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25498229)

  • 1. Potential role of positron emission tomography/magnetic resonance imaging in gastrointestinal and abdominal malignancies: preliminary experience.
    Teixera SR; Kohan AA; Paspulati RM; Rong R; Herrmann KA
    Semin Roentgenol; 2014 Oct; 49(4):321-33. PubMed ID: 25498229
    [No Abstract]   [Full Text] [Related]  

  • 2. 18F-FDG PET/CT imaging of multiple myxofibrosarcoma in left upper abdomen and chest wall.
    Yi C; Wang X; Shi X; Zhang X; Chen Z
    Nuklearmedizin; 2012; 51(6):N53-4. PubMed ID: 23250511
    [No Abstract]   [Full Text] [Related]  

  • 3. An unusual case of metastatic extramammary Paget's disease of the vulva identified by 18F-FDG PET/CT.
    Treglia G; Giovannini E; Bertagna F; Giovanella L; Malaggese M
    Rev Esp Med Nucl Imagen Mol; 2013; 32(6):402-3. PubMed ID: 23809514
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of positron emission tomography-computed tomography in gastrointestinal malignancies.
    Banks KP; Song WS
    Radiol Clin North Am; 2013 Sep; 51(5):799-831. PubMed ID: 24010907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography-magnetic resonance imaging: technical review.
    Muzic RF; DiFilippo FP
    Semin Roentgenol; 2014 Jul; 49(3):242-54. PubMed ID: 25497909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
    Donswijk ML; Hess S; Mulders T; Lam MG
    PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artifacts and diagnostic pitfalls in positron emission tomography-magnetic resonance imaging.
    Martinez-Rios C; Muzic RF; DiFilippo FP; Hu L; Rubbert C; Herrmann KA
    Semin Roentgenol; 2014 Jul; 49(3):255-70. PubMed ID: 25497910
    [No Abstract]   [Full Text] [Related]  

  • 9. Unusual loss of FDG uptake in recurrent GIST.
    Dunzinger A; Decker J; Kieberger A; Weis S; Pichler R
    Nuklearmedizin; 2014 Aug; 53(4):N35-7. PubMed ID: 25100559
    [No Abstract]   [Full Text] [Related]  

  • 10. Positron emission tomography/magnetic resonance imaging of the breast.
    Sher A; Vercher-Conejero JL; Muzic RF; Avril N; Plecha D
    Semin Roentgenol; 2014 Oct; 49(4):304-12. PubMed ID: 25498227
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal stromal tumours (GISTs) with a thousand faces: atypical manifestations and causes of misdiagnosis on imaging.
    Kim SW; Kim HC; Yang DM; Won KY
    Clin Radiol; 2016 Feb; 71(2):e130-42. PubMed ID: 26646370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of pediatric positron emission tomography-magnetic resonance imaging.
    Teixeira SR; Martinez-Rios C; Hu L; Bangert BA
    Semin Roentgenol; 2014 Oct; 49(4):353-66. PubMed ID: 25498232
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of MR-PET in abdominal and pelvic oncology.
    Fielding JR
    Abdom Imaging; 2015 Aug; 40(6):1351. PubMed ID: 26216376
    [No Abstract]   [Full Text] [Related]  

  • 15. An unusual intra-abdominal tumor of the gastrointestinal tract.
    Mukherjee U; Khurana A; Patil N
    Indian J Pathol Microbiol; 2018; 61(3):457-458. PubMed ID: 30004084
    [No Abstract]   [Full Text] [Related]  

  • 16. Positron emission tomography-magnetic resonance imaging in the evaluation of brain tumors: current status and future prospects.
    Nguyen N; Montagnese J; Rogers LR; Sher A; Wolansky L
    Semin Roentgenol; 2014 Jul; 49(3):275-89. PubMed ID: 25497912
    [No Abstract]   [Full Text] [Related]  

  • 17. The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
    Tokumoto N; Tanabe K; Misumi T; Fujikuni N; Suzuki T; Ohdan H
    Dig Surg; 2014; 31(2):79-86. PubMed ID: 24776690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of the gastrointestinal tract.
    Ferrucci JT
    Acad Radiol; 1995 Sep; 2 Suppl 2():S157-8. PubMed ID: 9419735
    [No Abstract]   [Full Text] [Related]  

  • 19. ¹⁸F-FDG PET/CT and contrast enhanced CT in differential diagnosis between leiomyoma and gastrointestinal stromal tumor.
    Hirose Y; Kaida H; Kawahara A; Kurata S; Ishibashi M; Abe T
    Hell J Nucl Med; 2015; 18(3):257-60. PubMed ID: 26574696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography-magnetic resonance imaging in oncologic diseases of the male and female pelvis.
    Kohan AA; Paspulati RM; Sherertz T; Mihaloew H; Herrmann K
    Semin Roentgenol; 2014 Oct; 49(4):334-44. PubMed ID: 25498230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.